نتایج جستجو برای: scopolamine

تعداد نتایج: 2136  

Journal: :Japanese journal of pharmacology 1993
H Ohta K Matsumoto H Watanabe M Shimizu

Paeoniflorin, a major constituent of peony root, has been demonstrated to attenuate the radial maze performance deficit produced by scopolamine. In the present study, to investigate the possible involvement of beta-adrenergic systems in the paeoniflorin antagonism of the scopolamine deficit, the effects of two beta-adrenoceptor antagonists, propranolol and atenolol, on the paeoniflorin effect w...

Journal: :Journal of applied physiology 2015
Aurélie P Weerts Lakshmi Putcha Stephen W Hoag Emma Hallgren Angelique Van Ombergen Paul H Van de Heyning Floris L Wuyts

Space motion sickness (SMS), a condition caused by an intravestibular conflict, remains an important obstacle that astronauts encounter during the first days in space. Promethazine is currently the standard treatment of SMS, but scopolamine is used by some astronauts to prevent SMS. However, the oral and transdermal routes of administration of scopolamine are known to have substantial drawbacks...

Journal: :Journal of psychopharmacology 1992
S E Molchan A M Mellow J L Hill H Weingartner R Martinez B Vitiello T Sunderland

Thyrotropin-releasing hormone (TRH), a neuromodulator and possibly a neurotransmitter in the central nervous system, was shown in a prior study of young normal volunteers to attenuate the memory impairment induced by the anticholinergic drug scopolamine. In the present study, the cognitive, behavioral and physiologic effects of high dose TRH (0.5 mg/kg), both alone and following administration ...

2015
Kaveh Tabrizian Najmeh Sadat Yaghoobi Mehrdad Iranshahi Jafar Shahraki Ramin Rezaee Mahmoud Hashemzaei

OBJECTIVES Auraptene (7-geranyloxycoumarin) (AUR), from Citrus species has shown anti-inflammatory, neuroprotective, and acetylcholinesterase (AChE) and beta-secretase inhibitory effects. Scopolamine is a nonselective muscarinic receptor antagonist which causes short-term memory impairments and is used for inducing animal model of Alzheimer's disease (AD). This research aimed to investigate the...

2016
Emma Bestaven Charline Kambrun Dominique Guehl Jean-René Cazalets Etienne Guillaud

BACKGROUND Motion sickness may be caused by a sensory conflict between the visual and the vestibular systems. Scopolamine, known to be the most effective therapy to control the vegetative symptoms of motion sickness, acts on the vestibular nucleus and potentially the vestibulospinal pathway, which may affect balance and motor tasks requiring both attentional process and motor balance. The aim o...

Journal: :iranian journal of basic medical sciences 0
mohammed rabbani department of pharmacology, isfahan pharmaceutical sciences research centre, school of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran golnaz vaseghi department of pharmacology, isfahan pharmaceutical sciences research centre, school of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran valiollah hajhashemi department of pharmacology, isfahan pharmaceutical sciences research centre, school of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran

objective(s) cannabinoids have been implicated in memory deficit. we examined the effect of am281, cannabinoid antagonist/inverse agonist in prevention of scopolamine-induced cognitive deficit. materials and methods  object recognition task was used to evaluate memory in mice. exploration time in the first and the second trial was recorded. the differences in exploration between a previously se...

Journal: :The Cochrane database of systematic reviews 2007
A B Spinks J Wasiak E V Villanueva V Bernath

BACKGROUND Motion sickness - the discomfort experienced when perceived motion disturbs the organs of balance - may include symptoms such as nausea, vomiting, pallor, cold sweats, hypersalivation, hyperventilation and headaches. The control and prevention of these symptoms have included pharmacological, behavioural and complementary therapies. Although scopolamine (hyoscine) has been used in the...

ژورنال: Basic and Clinical Neuroscience 2018
Rahimzadegan, Milad, Soodi, Maliheh,

Introduction: Scopolamine, a muscarinic cholinergic receptor antagonist, is widely used to induce memory impairment in experimental animals. The present study aims to compare memory impairment and oxidative stress following single and repeated doses administration of scopolamine. Methods: A group of rats received a single shot of scopolamine in different doses (0.5, 1, or 3 mg/kg, IP) 24 hours...

ژورنال: کومش 2019
Attarmoghadam, ‎Mahsa, Bandegi ‎, Ahmad Reza, Dadkhah, masoumeh, ghanbari, Ali, Moradi kor, ‎Nasroallah, Naghibi Nasab, Fateme Sadat, Nazari‎, ‎Maryam, Rashidy-pour‎, ‎Ali, Vafaei, Abbas Ali,

Introduction: Memory deficit is one of the clinical problems of Alzheimer’s disease that progressively leads to cognitive impairment and dementia. In the present study, the effect of Spirulina plathensis microalgae on the scopolamine-induced memory impairment was evaluated. Materials and Methods: Young female Wistar rats (30 days old) were used. Animals randomly were divided into 9 groups (Sali...

Medicinal plants have attracted global attention due to their high levels of antioxidant components for prohibiting or improving various diseases including brain and memory disorders. This study was designed to investigate if the antioxidant effect of Sidr (Zizyphusspina-christi) extract can help to improve the scopolamine induced impairment of memory in Wistar rats. Animals were randomly...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید